Delgado Montserrat G, Mauri Gerard, Vega Juan
Neurology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
BMJ Case Rep. 2012 Mar 27;2012:bcr1020115008. doi: 10.1136/bcr.10.2011.5008.
The authors present a 76-year-old female with high blood pressure and hypercholesterolaemia as cerebrovascular risk factors, who received intravenous thrombolysis for an ischaemic stroke with a progressive neurological improvement. She was asymptomatic at 48 h and she was transferred to the neurology department where antithrombotic treatment was initiated. She began to sit the following day when she suffered a massive pulmonary embolism (PE). Cardiological study showed patent foramen oval persistence and the presence of an atrial septa aneurysm, and paroxysmal atrial fibrillation. The delay of the onset of the antithrombotic treatment could have been determinant for the massive PE. Thromboembolic complications may be seen after intravenous thrombolysis for ischaemic stroke. An accurate treatment is needed in order to avoid potentially threatening complications such as massive PE.
作者报告了一名76岁女性,患有高血压和高胆固醇血症等脑血管危险因素,因缺血性中风接受静脉溶栓治疗后神经功能逐渐改善。48小时时她无症状,随后被转至神经内科并开始抗栓治疗。次日她开始坐起时发生了大面积肺栓塞(PE)。心脏检查显示卵圆孔未闭、房间隔瘤以及阵发性心房颤动。抗栓治疗开始时间的延迟可能是导致大面积PE的决定性因素。缺血性中风静脉溶栓后可能出现血栓栓塞并发症。需要进行准确的治疗以避免诸如大面积PE等潜在威胁生命的并发症。